A Comprehensive, Targeted NGS Approach to Assessing Molecular Diagnosis of Lysosomal Storage Diseases.


Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
30 10 2021
Historique:
received: 06 09 2021
revised: 25 10 2021
accepted: 27 10 2021
entrez: 27 11 2021
pubmed: 28 11 2021
medline: 15 2 2022
Statut: epublish

Résumé

With over 60 different disorders and a combined incidence occurring in 1:5000-7000 live births, lysosomal storage diseases (LSDs) represent a major public health problem and constitute an enormous burden for affected individuals and their families. Several reasons make the diagnosis of LSDs an arduous task for clinicians, including the phenotype and penetrance variability, the shared signs and symptoms, and the uncertainties related to biochemical enzymatic assay results. Developing a powerful diagnostic tool based on next generation sequencing (NGS) technology may help reduce the delayed diagnostic process for these families, leading to better outcomes for current therapies and providing the basis for more appropriate genetic counseling. Herein, we employed a targeted NGS-based panel to scan the coding regions of 65 LSD-causative genes. A reference group sample (

Identifiants

pubmed: 34828358
pii: genes12111750
doi: 10.3390/genes12111750
pmc: PMC8617937
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Int J Mol Sci. 2020 Sep 01;21(17):
pubmed: 32883051
Transl Sci Rare Dis. 2017 May 25;2(1-2):1-71
pubmed: 29152458
Best Pract Res Clin Endocrinol Metab. 2015 Mar;29(2):145-57
pubmed: 25987169
Mol Genet Genomic Med. 2019 Feb;7(2):e00527
pubmed: 30548430
J Mol Diagn. 2020 Apr;22(4):488-502
pubmed: 32036093
Biomolecules. 2020 Jul 26;10(8):
pubmed: 32722587
Cells. 2020 Aug 14;9(8):
pubmed: 32824006
Int J Mol Sci. 2021 Sep 17;22(18):
pubmed: 34576242
Rep Biochem Mol Biol. 2019 Jan;7(2):119-128
pubmed: 30805390
Genet Mol Biol. 2019;42(1 suppl 1):197-206
pubmed: 30985853
Autophagy. 2015;11(6):928-38
pubmed: 26075876
Int J Neonatal Screen. 2020 Apr 30;6(2):
pubmed: 32514487
Orphanet J Rare Dis. 2014 Apr 25;9:59
pubmed: 24767253
Sci Rep. 2017 Dec 15;7(1):17641
pubmed: 29247206
EMBO Mol Med. 2021 Feb 5;13(2):e12836
pubmed: 33459519
Hum Mutat. 2018 Dec;39(12):1739-1751
pubmed: 30098107
Orphanet J Rare Dis. 2016 Jan 25;11:8
pubmed: 26809617
Nat Rev Drug Discov. 2018 Feb;17(2):133-150
pubmed: 29147032
Nat Rev Dis Primers. 2018 Oct 1;4(1):27
pubmed: 30275469
Dev Disabil Res Rev. 2011;17(1):9-14
pubmed: 22447749

Auteurs

Valentina La Cognata (V)

Institute for Biomedical Research and Innovation (IRIB), National Research Council (CNR), 95126 Catania, Italy.

Sebastiano Cavallaro (S)

Institute for Biomedical Research and Innovation (IRIB), National Research Council (CNR), 95126 Catania, Italy.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH